Stability of Specific Immunoglobulin Secretion by EBV-Transformed Lymphoblastoid Cells and Human-Murine Heterohybridomas
- 1 August 1989
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 8 (4) , 377-389
- https://doi.org/10.1089/hyb.1989.8.377
Abstract
We have examined variables leading to the generation of stable, antigen-specific, human immunoglobulin-secreting cell lines. Peripheral blood B lymphocytes enriched for Thomsen-Friedenreich antigen (T antigen)-specific cells were transformed with Epstein-Barr virus. Lymphoblastoid cells (LC) reactive with T antigen were either expanded without cloning or cloned at limiting dilution and then fused with murine 653 cells. Uncloned LCs from three transformations secreting polyclonal anti-T antibody (7-18 μg/ml/106 cells/24 hr total immunoglobulin) were subcultured at 100 cells/well, and T antigen-reactive cultures pooled. These cultures quickly lost specific antibody secretion, presumably due to overgrowth by clones of unknown specificity. T antigen-reactive LCs that were cloned three times at limiting dilution secreted 0.2 - 6.1 μg/ml/106 cells/24 hr but died or stopped secreting specific immunoglobulin after 77 to 155 days in culture. Pooling T antigen-reactive clones after each cloning step did not increase the long term stability compared to unpooled clones (p - 0.2). Fusions between cloned LCs and 653 cells failed to yield viable hybrids in nine of ten attempts with seven different LC lines. In contrast, fusion of uncloned LCs and 653 cells resulted in the generation of viable immunoglobulin-secreting heterohybrids in 22 of 24 fusions. The heterohybridomas produced from fusion of uncloned T antigen-reactive cultures with 653 cells secreted significantly more antibody (frequency of cell lines secreting greater than 2 μg/ml/106cells/24 hr, p<0.01) and higher titers of antibody (frequency of cell lines secreting greater than four hemagglutination units of T antigen-specific antibody, p<0.03) than cloned lymphoblastoid cells. The hybrids maintained specific immunoglobulin secretion for longer in culture than either cloned or uncloned lymphoblastoid cell lines (p<0.001).This publication has 38 references indexed in Scilit:
- The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partnerJournal of Immunological Methods, 1986
- Xenohybridization of Epstein‐Barr Virus‐Transformed Cells for the Production of Human Monoclonal AntibodiesScandinavian Journal of Immunology, 1985
- T and Tn, General Carcinoma AutoantigensScience, 1984
- Production of human monoclonal IgG antibodies against Rhesus (D) antigen.Proceedings of the National Academy of Sciences, 1984
- Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.Proceedings of the National Academy of Sciences, 1982
- Theory and methods for immunization in culture and monoclonal antibody productionJournal of Immunological Methods, 1982
- T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populationsJournal of Immunological Methods, 1982
- A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell ActivatorImmunological Reviews, 1979
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Selection of Hybrids from Matings of Fibroblasts in vitro and Their Presumed RecombinantsScience, 1964